{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:56:15Z","timestamp":1792418175284,"version":"4.4.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:p>Dedifferentiated melanoma (DM) and undifferentiated melanoma (UM) is defined as a primary or metastatic melanoma showing transition between conventional and undifferentiated components (DM) or lacking histologic and immunophenotypic features of melanoma altogether (UM). The latter is impossible to verify as melanoma by conventional diagnostic tools alone. We herein describe our experience with 35 unpublished cases to expand on their morphologic, phenotypic, and genotypic spectrum, along with a review of 50 previously reported cases (total: 85) to establish the diagnostic criteria. By definition, the dedifferentiated\/undifferentiated component lacked expression of 5 routinely used melanoma markers (S100, SOX10, Melan-A, HMB45, Pan-melanoma). Initial diagnoses (known in 66 cases) were undifferentiated\/unclassified pleomorphic sarcoma (n=30), unclassified epithelioid malignancy (n=7), pleomorphic rhabdomyosarcoma (n=5), other specific sarcoma types (n=6), poorly differentiated carcinoma (n=2), collision tumor (n=2), atypical fibroxanthoma (n=2), and reactive osteochondromatous lesion (n=1). In only 11 cases (16.6%) was a diagnosis of melanoma considered. Three main categories were identified: The largest group (n=56) comprised patients with a history of verified previous melanoma who presented with metastatic DM or UM. Axillary or inguinal lymph nodes, soft tissue, bone, and lung were mainly affected. A melanoma-compatible mutation was detected in 35 of 48 (73%) evaluable cases: <jats:italic toggle=\"yes\">BRAF<\/jats:italic> (n=20; 40.8%), and <jats:italic toggle=\"yes\">NRAS<\/jats:italic> (n=15; 30.6%). The second group (n=15) had clinicopathologic features similar to group 1, but a melanoma history was lacking. Axillary lymph nodes (n=6) was the major site in this group followed by the lung, soft tissue, and multiple site involvement. For this group, <jats:italic toggle=\"yes\">NRAS<\/jats:italic> mutation was much more frequent (n=9; 60%) than <jats:italic toggle=\"yes\">BRAF<\/jats:italic> (n=3; 20%) and <jats:italic toggle=\"yes\">NF1<\/jats:italic> (n=1; 6.6%). The third category (n=14) comprised primary DM (12) or UM (2). A melanoma-compatible mutation was detected in only 7 cases: <jats:italic toggle=\"yes\">BRAF<\/jats:italic> (n=2), <jats:italic toggle=\"yes\">NF1<\/jats:italic> (n=2), <jats:italic toggle=\"yes\">NRAS<\/jats:italic> (n=2), and <jats:italic toggle=\"yes\">KIT<\/jats:italic> exon 11 (n=1). This extended follow-up study highlights the high phenotypic plasticity of DM\/UM and indicates significant underrecognition of this aggressive disease among general surgical pathologists. The major clues to the diagnosis of DM and UM are: (1) presence of minimal differentiated clone in DM, (2) earlier history of melanoma, (3) undifferentiated histology that does not fit any defined entity, (4) locations at sites that are unusual for undifferentiated\/unclassified pleomorphic sarcoma (axilla, inguinal, neck, digestive system, etc.), (5) unusual multifocal disease typical of melanoma spread, (6) detection of a melanoma-compatible gene mutation, and (7) absence of another genuine primary (eg, anaplastic carcinoma) in other organs.<\/jats:p>","DOI":"10.1097\/pas.0000000000001645","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T16:14:36Z","timestamp":1608826476000},"page":"240-254","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":88,"title":["Dedifferentiated and Undifferentiated Melanomas"],"prefix":"10.1097","volume":"45","author":[{"given":"Abbas","family":"Agaimy","sequence":"first","affiliation":[{"name":"Institute of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Stoehr","sequence":"additional","affiliation":[{"name":"Institute of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annkathrin","family":"Hornung","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg (FAU), Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Popp","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg (FAU), Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Erdmann","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg (FAU), Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Heinzerling","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg (FAU), Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen"},{"name":"Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Institute of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,18]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2559.2000.00894.x","article-title":"Morphological and immunophenotypic variations in malignant melanoma","volume":"36","author":"Banerjee","year":"2000","journal-title":"Histopathology"},{"issue":"suppl 2","key":"R2-20250608","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1038\/modpathol.3800516","article-title":"Unusual variants of malignant melanoma","volume":"19","author":"Magro","year":"2006","journal-title":"Mod Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/DAD.0000000000001218","article-title":"Uncommon histopathological variants of malignant melanoma: part 1","volume":"41","author":"Cota","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/DAD.0000000000001226","article-title":"Uncommon histopathological variants of malignant melanoma: part 2","volume":"41","author":"Saggini","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/DAD.0b013e3181b34a19","article-title":"Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum","volume":"32","author":"Plaza","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/his.12305","article-title":"BRAF mutation in \u201csarcomas\u201d: a possible method to detect dedifferentiated melanomas","volume":"64","author":"Cipriani","year":"2014","journal-title":"Histopathology"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/PAS.0000000000000527","article-title":"Metastatic malignant melanoma with complete loss of differentiation markers (undifferentiated\/dedifferentiated melanoma): analysis of 14 patients emphasizing phenotypic plasticity and the value of molecular testing as surrogate diagnostic marker","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/1097-0142(197806)41:6<2250::AID-CNCR2820410626>3.0.CO;2-W","article-title":"Malignant fibrous histiocytoma: an analysis of 200 cases","volume":"41","author":"Weiss","year":"1978","journal-title":"Cancer"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00000478-199203000-00001","article-title":"Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma","volume":"16","author":"Fletcher","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R10-20250608","first-page":"210","article-title":"Malignant fibrous histiocytoma: morphologic pattern or pathologic entity?","volume":"12","author":"Hollowood","year":"1995","journal-title":"Semin Diagn Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.anndiagpath.2018.10.006","article-title":"Subclassification of pleomorphic sarcomas: how and why should we care?","volume":"37","author":"Hornick","year":"2018","journal-title":"Ann Diagn Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00000478-198905000-00003","article-title":"Desmoplastic malignant melanoma and its variants: a study of 45 cases","volume":"13","author":"Jain","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ajcp\/103.6.772","article-title":"S100 protein and HMB-45 negative \u201crhabdoid\u201d malignant melanoma: a totally dedifferentiated malignant melanoma?","volume":"103","author":"Laskin","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/jcp.49.11.950","article-title":"Malignant melanoma showing smooth muscle differentiation","volume":"49","author":"Banerjee","year":"1996","journal-title":"J Clin Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJMc0707079","article-title":"Malignant melanoma with metastatic rhabdomyosarcomatoid transdifferentiation","volume":"358","author":"Gattenl\u00f6hner","year":"2008","journal-title":"N Engl J Med"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/DAD.0b013e31819afdaa","article-title":"Metastatic desmoplastic malignant melanoma associated with low-grade myofibroblastic sarcoma","volume":"31","author":"Kacerovska","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/PAS.0b013e31822280d8","article-title":"Metastatic melanoma with striking adenocarcinomatous differentiation illustrating phenotypic plasticity in melanoma","volume":"35","author":"Jalas","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4103\/0377-4929.107806","article-title":"A case of collision tumor or transdifferentiation between malignant melanoma and leiomyosarcoma","volume":"55","author":"Ul-Mulk","year":"2012","journal-title":"Indian J Pathol Microbiol"},{"key":"R19-20250608","first-page":"468","article-title":"Comparative genomic hybridization in a case of melanoma that loses expression of S100, HMB45, Melan A and tyrosinase in metastasis","volume":"7","author":"Guo","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"R20-20250608","first-page":"1658","article-title":"Micropthalmia transcription factor (MITF) as a diagnostic marker for metastatic melanomas negative for other melanoma markers","volume":"6","author":"Guo","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/PAS.0000000000000201","article-title":"Desmoplastic melanoma with sarcomatoid dedifferentiation","volume":"38","author":"Kiuru","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/1066896914531817","article-title":"Melanomas with rhabdomyosarcomatous differentiation: two further cases of a rare pathologic pitfall","volume":"22","author":"Shenjere","year":"2014","journal-title":"Int J Surg Pathol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/1066896913510031","article-title":"Rhabdomyoblastic differentiation in metastatic melanoma: making sense of a rare but complex form of mimicry","volume":"22","author":"Reilly","year":"2014","journal-title":"Int J Surg Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/PAS.0000000000000647","article-title":"NRASQ61R and BRAFV600E mutation-specific immunohistochemistry is a helpful tool to diagnose metastatic undifferentiated\/dedifferentiated melanomas","volume":"40","author":"Uguen","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/DAD.0000000000000478","article-title":"Malignant melanoma with rhabdomyosarcomatous differentiation: a case report","volume":"38","author":"Antonov","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/DAD.0000000000000716","article-title":"Living on the edge: diagnosing sarcomatoid melanoma using histopathologic cues at the edge of a dedifferentiated tumor: a report of 2 cases and review of the literature","volume":"39","author":"Erstine","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/cup.13122","article-title":"Metastatic melanoma with dedifferentiation and extensive rhabdomyosarcomatous heterologous component","volume":"45","author":"Campbell","year":"2018","journal-title":"J Cutan Pathol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/DAD.0000000000001236","article-title":"Undifferentiated sarcoma as intermediate step in the progression of malignant melanoma to rhabdomyosarcoma. histologic, immunohistochemical, and molecular studies of a new case of malignant melanoma with rhabdomyosarcomatous differentiation","volume":"41","author":"Tran","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41379-018-0161-0","article-title":"Detection of driver mutations in BRAF can aid in diagnosis and early treatment of dedifferentiated metastatic melanoma","volume":"32","author":"Alrabadi","year":"2019","journal-title":"Mod Pathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/1066896919857148","article-title":"Primary dedifferentiated amelanotic anorectal melanoma: report of a rare case","volume":"27","author":"Bell","year":"2019","journal-title":"Int J Surg Pathol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/DAD.0000000000001322","article-title":"Dedifferentiated melanoma with expression of cytokeratin and GATA3 in a patient with history of breast carcinoma","volume":"41","author":"Alkhasawneh","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/CMR.0000000000000636","article-title":"Genomic profiling of a dedifferentiated mucosal melanoma following exposure to immunotherapy","volume":"30","author":"Prior","year":"2019","journal-title":"Melanoma Res"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2559.2007.02823.x","article-title":"Divergent differentiation in malignant melanomas: a review","volume":"52","author":"Banerjee","year":"2008","journal-title":"Histopathology"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2559.1998.00494.x","article-title":"Diagnostic lessons of mucosal melanoma with osteocartilaginous differentiation","volume":"33","author":"Banerjee","year":"1998","journal-title":"Histopathology"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00000372-199406000-00003","article-title":"Epithelial markers in malignant melanoma. A study of primary lesions and their metastases","volume":"16","author":"Ben-Izhak","year":"1994","journal-title":"Am J Dermatopathol"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0046-8177(90)90183-6","article-title":"Metastatic amelanotic melanoma simulating giant-cell tumor of bone","volume":"21","author":"Daroca","year":"1990","journal-title":"Hum Pathol"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/PAS.0b013e31822e0907","article-title":"Epithelioid rhabdomyosarcoma: clinicopathologic analysis of 16 cases of a morphologically distinct variant of rhabdomyosarcoma","volume":"35","author":"Jo","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.MP.0000067686.34489.50","article-title":"PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen","volume":"16","author":"Rochaix","year":"2003","journal-title":"Mod Pathol"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.pas.0000152137.81771.5b","article-title":"Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers","volume":"29","author":"Busam","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/PAS.0b013e31823651cb","article-title":"KBA62 and PNL2: 2 new melanoma markers-immunohistochemical analysis of 1563 tumors including metastatic, desmoplastic, and mucosal melanomas and their mimics","volume":"36","author":"Aung","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0000000000001134","article-title":"PRAME expression in melanocytic tumors","volume":"42","author":"Lezcano","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/PAP.0000000000000101","article-title":"Dedifferentiated liposarcoma: updates on morphology, genetics, and therapeutic strategies","volume":"23","author":"Thway","year":"2016","journal-title":"Adv Anat Pathol"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/bjc.2013.622","article-title":"Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations","volume":"109","author":"Heinzerling","year":"2013","journal-title":"Br J Cancer"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/1878-0261.12050","article-title":"NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics","volume":"11","author":"Cirenajwis","year":"2017","journal-title":"Mol Oncol"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/CMR.0000000000000628","article-title":"Frequency of mutations in BRAF, NRAS, and KIT in different populations and histological subtypes of melanoma: a systemic review","volume":"30","author":"Guti\u00e9rrez-Casta\u00f1eda","year":"2020","journal-title":"Melanoma Res"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1600-0463.2012.02878.x","article-title":"Mutational analysis of PIK3CA, JAK2, BRAF, FOXL2, IDH1, AKT1 and EZH2 oncogenes in sarcomas","volume":"120","author":"Je","year":"2012","journal-title":"APMIS"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","article-title":"Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma","volume":"121","author":"Schindler","year":"2011","journal-title":"Acta Neuropathol"},{"key":"R49-20250608","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/his.12021","article-title":"BRAF V600E and KRAS G12S mutations in peripheral nerve sheath tumours","volume":"62","author":"Serrano","year":"2013","journal-title":"Histopathology"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cncr.29733","article-title":"RAS\/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas","volume":"122","author":"Serrano","year":"2016","journal-title":"Cancer"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41379-018-0200-x","article-title":"Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma","volume":"32","author":"Shanmugam","year":"2019","journal-title":"Mod Pathol"},{"key":"R52-20250608","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3324\/haematol.2019.230375","article-title":"Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups","volume":"105","author":"Egan","year":"2020","journal-title":"Haematologica"},{"key":"R53-20250608","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/1066896914567333","article-title":"Challenges in the differential diagnosis of interdigitating dendritic cell sarcoma of intraparotid lymph node vs. metastatic malignant melanoma with unknown primary site","volume":"23","author":"Galli","year":"2015","journal-title":"Int J Surg Pathol"},{"key":"R54-20250608","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/PAS.0000000000000678","article-title":"Spindle cell melanoma and interdigitating dendritic cell sarcoma: do they represent the same process?","volume":"40","author":"Stowman","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R55-20250608","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/PAS.0000000000000746","article-title":"Oncogene status of an interdigitating dendritic cell sarcoma: recurrent mutations in NF1, TP53, and ARID2 shared with melanoma","volume":"40","author":"Hillen","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R56-20250608","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/bjc.2013.143","article-title":"Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice","volume":"108","author":"Heinzerling","year":"2013","journal-title":"Br J Cancer"},{"key":"R57-20250608","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40291-015-0133-8","article-title":"Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assay","volume":"19","author":"Greco","year":"2015","journal-title":"Mol Diagn Ther"},{"key":"R58-20250608","doi-asserted-by":"crossref","first-page":"20411","DOI":"10.1073\/pnas.1909021116","article-title":"Intragenomic variability and extended sequence patterns in the mutational signature of ultraviolet light","volume":"116","author":"Lindberg","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"R59-20250608","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0000000000001231","article-title":"UV signature mutations reclassify salivary high-grade neuroendocrine carcinomas as occult metastatic cutaneous merkel cell carcinomas","volume":"43","author":"Sun","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R60-20250608","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/s41379-020-0594-0","article-title":"Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma","volume":"33","author":"Yang","year":"2020","journal-title":"Mod Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T22:05:13Z","timestamp":1749420313000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001645"}},"subtitle":["Report of 35 New Cases With Literature Review and Proposal of Diagnostic Criteria"],"short-title":[],"issued":{"date-parts":[[2020,12,18]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001645","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,18]]}}}